European drug agency sets out plans to publish clinical trial data from 2014

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8423 (Published 12 December 2012)
Cite this as: BMJ 2012;345:e8423

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Rory Watson
  1. 1Brussels

The European Medicines Agency has set out how it intends to ensure greater access to clinical trial data. The year long process will see the new policy in force from 1 January 2014 and reflects the agency’s move towards a more proactive publication policy.1

The final route map reflects input from experts across the European healthcare system and the drug industry at a workshop in London on 22 November. The agency’s director, Guido Rasi, made clear to participants the new policy of publishing clinical trial data once the marketing authorisation …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL